Indexus Biomedical Indexus Biomedical is a company developing multifunctional technologies and products designed to deliver in-vitro diagnostic tests. | ![]() Wondfo Guangzhou Wondfo Biotech is a biotechnology company that specializes in R&D, production, sales, and service of point-of-care testing products and provides rapid diagnosis and chronic disease management solutions. | Senzime Senzime is a company that develops monitoring systems to assess patients' biochemical and physiological processes before, during, and after surgery. | Chai Chai is a company developing medical devices that detect pathogens, bacteria, virus, allergen, gene, species, or DNA tracer on-site at the point of need.
| ||
Founding Date | Founding Date 2013 | Founding Date 1992 | Founding Date 1999 | Founding Date 2013 | Founding Date 2015 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Durham, US HQ | Locations Guangzhou, CN HQ | Locations Uppsala, SE HQ Watertown, US | Locations Santa Clara, US HQ | Locations Leuven, BE HQ |
Employees | Employees 3 | Employees 3,197 | Employees 54 | Employees 75 | Employees 771% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.7 b | Valuation ($) 75.9 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥2.1b (FY, 2025) | Revenue (est.) kr104m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods ¥897.9m (FY, 2025) | Cost of goods kr45.8m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ¥1.2b (FY, 2025) | Gross profit kr59.3m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income (¥69.7m) (FY, 2025) | Net income (kr137.4m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 2m (about 9 years ago) | Latest funding round $ 15.2m (about 6 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 364k | Total funding raised $ 3.4m | Total funding raised $ 17.1m |

Guangzhou Wondfo Biotech is a biotechnology company that specializes in R&D, production, sales, and service of point-of-care testing products and provides rapid diagnosis and chronic disease management solutions.
View companySenzime is a company that develops monitoring systems to assess patients' biochemical and physiological processes before, during, and after surgery.
View companyChai is a company developing medical devices that detect pathogens, bacteria, virus, allergen, gene, species, or DNA tracer on-site at the point of need.
View companymiDiagnostics is a company providing diagnostic solutions.
View company